A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMAVROUDIS, D; PAPPAS, P; SAMONIS, G et al.Annals of oncology. 2003, Vol 14, Num 2, pp 304-312, issn 0923-7534, 9 p.Article

Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: A multicenter phase II studyVAMVAKAS, L; KAKOLYRIS, S; GEORGOULIAS, V et al.American journal of clinical oncology. 2002, Vol 25, Num 1, pp 65-70, issn 0277-3732Article

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy : a multicenter phase II trialALEXOPOULOS, K; KOUROUSSIS, C; GEORGOULIAS, V et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 257-262, issn 0344-5704Article

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II studyGEORGOULIAS, V; KOUROUSSIS, C; ARDAVANIS, A et al.British journal of cancer. 2004, Vol 91, Num 3, pp 482-488, issn 0007-0920, 7 p.Article

Front-line treatment of metastatic breast cancer with docetaxel and epirubicin : A multicenter dose-escalation studyKOUROUSSIS, C; XYDAKIS, E; SAMONIS, G et al.Annals of oncology. 1999, Vol 10, Num 5, pp 547-552, issn 0923-7534Article

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy : A multicenter phase II studyANDROULAKIS, N; KOUROUSSIS, C; KOTSAKIS, A et al.Annals of oncology. 1998, Vol 9, Num 10, pp 1127-1130, issn 0923-7534Article

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use programPALLIS, A. G; MAVROUDIS, D; ANDROULAKIS, N et al.Lung cancer. 2003, Vol 40, Num 3, pp 301-307, issn 0169-5002, 7 p.Article

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancerMAVROUDIS, D; PAPADAKIS, E; VLACHONICOLIS, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 463-470, issn 0923-7534Article

Spontaneous spondylodiscitis caused by Klebsiella pneumoniaeKOUROUSSIS, C; GEORGOULIAS, V; SOUGLAKOS, J et al.Infection. 1999, Vol 27, Num 6, pp 368-369, issn 0300-8126Article

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerSTATHOPOULOS, G. P; RIGATOS, S. K; STATHOPOULOS, J. G et al.Annals of oncology. 2003, Vol 14, Num 3, pp 388-394, issn 0923-7534, 7 p.Article

Front-line treatment of advanced breast cancer with docetaxel and epirubicin : A multicenter phase II studyMAVROUDIS, D; ALEXOPOULOS, A; RIGATOS, G et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1249-1254, issn 0923-7534Article

Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancerKOUROUSSIS, C; ANDROULAKIS, N; VLACHONIKOLIS, J et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 862-869, issn 0732-183XArticle

Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer : A multicenter phase II study of the Greek Cooperative Group for Lung CancerGEORGOULIAS, V; ANDROULAKIS, N; HATZIDAKI, D et al.Lung cancer. 1998, Vol 21, Num 3, pp 213-220, issn 0169-5002Article

Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancerMAVROUDIS, D; PAPAKOTOULAS, P; KENTEPOZIDIS, N et al.Annals of oncology. 2010, Vol 21, Num 1, pp 48-54, issn 0923-7534, 7 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursANDROULAKIS, N; KOUROUSSIS, C; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 15, pp 1992-1997, issn 0959-8049Article

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine : A multicenter phase II trialGEORGOULIAS, V; KOUROUSSIS, C; HATZAKIS, K et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 914-920, issn 0732-183XArticle

Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma : a randomized phase II study of the Hellenic Cooperative Oncology GroupBAFALOUKOS, D; TSOUTSOS, D; CHRISTODOULOU, C et al.Annals of oncology. 2005, Vol 16, Num 6, pp 950-957, issn 0923-7534, 8 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancerXENIDIS, N; VLACHONIKOLIS, I; LIANIDOU, E et al.Annals of oncology. 2003, Vol 14, Num 6, pp 849-855, issn 0923-7534, 7 p.Article

A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 60, Num 3, pp 207-213, issn 0030-2414Article

Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase ii studyALEXOPOULOS, A; KOUROUSSIS, C; RIGATOS, G et al.Annals of oncology. 2001, Vol 12, Num 6, pp 793-798, issn 0923-7534Article

Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor : A phase II study of the Greek Cooperative Group for Pancreatic CancerSTATHOPOULOS, G. P; MAVROUDIS, D; TSAVARIS, N et al.Annals of oncology. 2001, Vol 12, Num 1, pp 101-103, issn 0923-7534Article

Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatinKAKOLYRIS, S; KOUROUSSIS, C; KALBAKIS, K et al.Annals of oncology. 2000, Vol 11, Num 6, pp 757-760, issn 0923-7534Article

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy : A report of five casesKOUROUSSIS, C; SAMONIS, G; ANDROULAKIS, N et al.American journal of clinical oncology. 2000, Vol 23, Num 3, pp 309-313, issn 0277-3732Article